Volume 26, Number 9—September 2020
Research
Heterogeneity of Dengue Illness in Community-Based Prospective Study, Iquitos, Peru
Table 1
Characteristic | Total | Index | Contact |
---|---|---|---|
No. participants | 79 | 55 | 24 |
No. surveys |
429 |
309 |
120 |
Sex, no. (%) | |||
M | 38 (48) | 27 (49) | 11 (46) |
F |
41 (52) |
28 (51) |
13 (54) |
Median age, y (IQR) | 17 (12–27.5) | 17 (14–26) | 14.5 (9.5–31) |
Day at diagnosis (IQR) |
3 (2–4) |
4 (3–5) |
2 (1–3) |
Serotype, % | |||
DENV-2 | 76 (96) | 53 (96) | 23 (96) |
DENV-3 |
3 (4) |
2 (4) |
1 (4) |
WHO suspected dengue† (%) | 67 (85) | 51 (93) | 16 (67) |
Warning signs, no. (%) | 20 (25) | 18 (33) | 2 (8) |
Hospitalized, no. (%) | 7 (9) | 6 (11) | 1 (4) |
*DENV, dengue virus; IQR, interquartile range; WHO, World Health Organization.
†Persons who met the 2009 WHO criteria for suspected dengue (see Methods).
Page created: June 03, 2020
Page updated: August 18, 2020
Page reviewed: August 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.